MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

    Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
  • 2016 International Congress

    Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension

    K.E. McDonell, C.A. Shibao, I. Biagginoi, D. Robertson, D.O. Claassen (Nashville, TN, USA)

    Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…
  • 2016 International Congress

    A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)

    V.K. Hinson, J. Elm, A. Delambo, T. Turner (Charleston, SC, USA)

    Objective: To evaluate (1) safety and tolerability of ATM and (2) effects of ATM on attention and executive functioning in PD- MCI after 10 weeks…
  • 2016 International Congress

    Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients

    C. Koros, M. Stamelou, I. Beratis, N. Papagiannakis, A.M. Simitsi, D. Papadimitriou, S. Fragiadaki, D. Kontaxopoulou, S.G. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T α-synuclein (SNCA) related Parkinson's disease (PD) as compared to sporadic Parkinson's disease (sPD) patients. Background:…
  • 2016 International Congress

    Two cases of parkinsonism with atypical genetics

    J.A. Ribeiro, F. Moreira, J. Beato-Coelho, A.S. Morgadinho, M.R. Almeida, C. Januário (Coimbra, Portugal)

    Objective: To report and discuss two unrelated patients carrying heterozygous mutations in both Parkin (PARK2) and Glucocerebrosidase (GBA) gene, with atypical Parkinsonian features. Background: Parkin…
  • 2016 International Congress

    Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia

    M.D. Maldonado (Santiago, Chile)

    Objective: This case report describes the use of sensory augmentation and an exercise routine to improve balance and gait in a patient with lithium-induced ataxia.…
  • 2016 International Congress

    Brain mechanisms underlying visual processing in Parkinson’s disease

    I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

    Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…
  • 2016 International Congress

    Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

    T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)

    Objective: The our intention was to investigate a dynamics of cognitive decline in patients with different side of onset parkinsonism in view of visual dysfunction…
  • 2016 International Congress

    Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

    R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)

    Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…
  • 2016 International Congress

    Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation

    A. Greuel, C.J. Lewis, F. Maier, R. Dano, S. Heintz, W. Ruch, C. Eggers (Cologne, Germany)

    Objective: To assess humor perception in Parkinson's disease (PD) patients by comparison to a matched sample of healthy controls (HC), and to investigate the effects…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley